Trial intelligence / Profile preview

Xiaozhongcuyu Tang for postoperative anal fistula wound healing

ChiCTR2400082363Phase 2Not yet recruiting

Sponsor
Xi'an Hospital of Traditional Chinese Medicine
Start
Mar 2024
Countries
1
01

Overview

Phase 2 trial of xiaozhongcuyu tang in anal fistula (2 arms), sponsored by Xi'an Hospital of Traditional Chinese Medicine. Primary endpoint: Serum growth factor concentration. Planned start Mar 2024; status: not yet recruiting.

02

Drugs

xiaozhongcuyu tang
03

Conditions

anal fistula

Beyond the preview

Go deeper on ChiCTR2400082363.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400082363.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call